Biotech Values

[ghmm]

XNPT:

Peter do you think the Phase 1 trial would be along the lines of the L-Dopa trial in terms of duration or would there be other factors making it a longer process to find the optimal dose/formulation? So perhaps if they start end of Q2 '12 they have results (and hopefully a formulation to go forward with) in just 1 quarter?

http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-newsArticle&ID=1117889&highlight=

http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-newsArticle&ID=1090991&highlight=